Literature DB >> 9510276

Concurrent comparison of endoluminal versus open repair in the treatment of abdominal aortic aneurysms: analysis of 303 patients by life table method.

J May1, G H White, W Yu, C N Ly, R Waugh, M S Stephen, M Arulchelvam, J P Harris.   

Abstract

PURPOSE: The aim of this study was to compare the outcome of consecutive patients with abdominal aortic aneurysm (AAA) treated concurrently by open operation and endoluminal intervention by the same surgeons during a defined interval.
METHODS: Between May 1992 and May 1996, 362 consecutive patients with AAA underwent repair. Fifty-three patients who underwent open operations for ruptured AAA plus two patients who underwent endoluminal repair of false AAA and four patients who underwent secondary endoluminal repair of AAA were excluded, leaving 303 patients who underwent elective repair of true AAA in the study. The elective operations were conventional open repair (OR) in 195 patients (151 men, 44 women; mean age, 69 years) and endoluminal repair (ER) in 108 patients (100 men, 8 women; mean age, 70 years). The decision to perform ERwas based on comorbidities that precluded open repair (n = 48) and patient choice (n = 60). Graft configuration in the open repair group was tubular (n = 180) and bifurcated (n = 15), and in the ER group tubular (n = 48), aortoiliac/femoral (n = 25), and bifurcated (n = 35). All procedures were performed in the operating department, and radiographic guidance was used in the ER group. Follow-up was by interview, examination, and telephone. In addition, contrast-enhanced computed tomography was performed within the first 10 days after operation, 6 months and 12 months after operation, and then annually thereafter in the ER group. Outcome measures were successful exclusion of the aneurysm sac from the general circulation and survival. Data were analyzed by the life table method. Other outcome measures were length of hospital stay, length of intensive care unit stay, and operative blood loss.
RESULTS: No significant difference was found between the perioperative mortality rate for OR (11 deaths [5.6%] in 195 patients) and ER (six deaths [5.6%] in 108 patients). Three of the six deaths in the latter group occurred in patients with successful ER, and three occurred in 18 patients with failed ER who were converted to OR. Similarly, no significant difference was seen in the survival rate between the endoluminal and open repair groups when analyzed by the log-rank test (p = 0.14). The rate of graft failure, however, was significantly higher in the ER group than in the OR group (Fisher's exact test, p < 0.001). Success in the ER group was defined as continuing graft function without endoleak or conversion to open repair. Kaplan-Meier curve for graft failure times for the endoluminal group revealed a 3-year graft success probability of 70%.
CONCLUSIONS: This study suggests that ER is safe, sharing the same perioperative mortality risk as OR despite 44% of the ER group being rejected as unfit for OR. Conventional open repair is the most reliable method of successfully managing AAA. The endoluminal method, however, results in shorter length of hospital stay, shorter length of intensive care unit stay, and less blood loss than the open method. Patients who opt for the endoluminal method of repair should be made aware that the minimally invasive technique carries the disadvantage of a higher failure rate.

Entities:  

Mesh:

Year:  1998        PMID: 9510276     DOI: 10.1016/s0741-5214(98)70352-0

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  19 in total

1.  Stent-graft repair for abdominal aortic aneurysm.

Authors:  P G Kalman
Journal:  CMAJ       Date:  1999-11-02       Impact factor: 8.262

2.  Implementation of a successful endovascular surgical program in a non-teaching tertiary-care centre in Ontario.

Authors:  Rod P N Willoughby; John A Fenton; Santosh R Pudupakkam; Robert A Greco; Evan W D Roberts; Guy DeRose; Stewart Kribs
Journal:  Can J Surg       Date:  2004-06       Impact factor: 2.089

3.  Surgical treatment of abdominal aortic aneurysms located close to the visceral arteries: report of three cases.

Authors:  H Sako; T Hadama; O Shigemitsu; S Miyamoto; H Anai; T Soeda; S Urabe; T Wada; E Iwata
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Evidence-Based Surgery. Users' guide to the surgical literature: how to assess an article on health-related quality of life.

Authors:  Achilleas Thoma; Sylvie D Cornacchi; Peter J Lovrics; Charlie H Goldsmith
Journal:  Can J Surg       Date:  2008-06       Impact factor: 2.089

5.  Endovascular grafts and other image-guided catheter-based adjuncts to improve the treatment of ruptured aortoiliac aneurysms.

Authors:  T Ohki; F J Veith
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

6.  Devices used for endovascular aneurysm repair: past, present, and future.

Authors:  Benjamin M Jackson; Jeffrey P Carpenter
Journal:  Semin Intervent Radiol       Date:  2009-03       Impact factor: 1.513

7.  Endovascular repair of abdominal aortic aneurysms: risk stratified outcomes.

Authors:  Elliot L Chaikof; Peter H Lin; William T Brinkman; Thomas F Dodson; Victor J Weiss; Alan B Lumsden; Thomas T Terramani; Sasan Najibi; Ruth L Bush; Atef A Salam; Robert B Smith
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

8.  Abdominal aortic aneurysm: a 6-year comparison of endovascular versus transabdominal repair.

Authors:  W S Moore; V S Kashyap; C L Vescera; W J Quiñones-Baldrich
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

9.  Long-term outcomes after endovascular abdominal aortic aneurysm repair: the first decade.

Authors:  David C Brewster; John E Jones; Thomas K Chung; Glenn M Lamuraglia; Christopher J Kwolek; Michael T Watkins; Thomas M Hodgman; Richard P Cambria
Journal:  Ann Surg       Date:  2006-09       Impact factor: 12.969

10.  Defining high-risk patients for endovascular aneurysm repair.

Authors:  Natalia Egorova; Jeannine K Giacovelli; Annetine Gelijns; Giampaolo Greco; Alan Moskowitz; James McKinsey; K Craig Kent
Journal:  J Vasc Surg       Date:  2009-09-26       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.